Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1984 Jun;19(6):884–887. doi: 10.1128/jcm.19.6.884-887.1984

Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types.

J R Tagg
PMCID: PMC271204  PMID: 6381528

Abstract

Application of a bacteriocin-typing scheme that had been designed to minimize the inhibitory effects of hydrogen peroxide and acidic metabolites demonstrated a high incidence (72%) of bacteriocin-like inhibitors belonging to 5 different production (P) types in 61 strains of group A streptococci isolated in association with the development of acute glomerulonephritis. By contrast, only 4 of 16 (25%) rheumatic fever-associated strains were inhibitor positive, and 3 of these strains were P type 604, a P type not detected in any of the nephritis isolates. The P type designation was found to be identical for all inhibitor-positive strains within each particular M serotype, regardless of whether the source was a nephritis patient or an individual having an uncomplicated streptococcal infection. The incidence of inhibitor-positive strains was particularly high in strains of M types 2, 4, 12, 25, 57, and 60; it was moderately high in M types 49, 52, and 55 and absent in M1 and M3. Although the results indicate that the bacteriocin-like inhibitors detected in this study are probably unlikely to have a direct pathogenetic role in either rheumatic fever or acute glomerulonephritis, it does seem that the present P-typing scheme is a useful epidemiological tool, particularly for the presumptive identification of and differentiation among group A streptococcus strains of nephritogenic serotypes.

Full text

PDF
884

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aggarwal P., Prakash K., Sharma K. B. Production of streptocins by beta hemolytic streptococci with special reference to rheumatic heart diseases. J Commun Dis. 1982 Jun;14(2):141–146. [PubMed] [Google Scholar]
  2. Johnson D. W., Tagg J. R., Wannamaker L. W. Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol. 1979 Nov;12(4):413–427. doi: 10.1099/00222615-12-4-413. [DOI] [PubMed] [Google Scholar]
  3. Kuttner A. G. Production of bacteriocines by group A streptococci with special reference to the nephritogenic types. J Exp Med. 1966 Sep 1;124(3):279–291. doi: 10.1084/jem.124.3.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Malke H., Starke R., Jacob H. E., Köhler W. Bacteriocine-like activity of group-A streptococci due to the production of peroxide. J Med Microbiol. 1974 Aug;7(3):367–374. doi: 10.1099/00222615-7-3-367. [DOI] [PubMed] [Google Scholar]
  5. Noble R. C., Vosti K. L. Biologic and immunologic comparison of nephritogenic and nonnephritogenic strains of group A, M-type 12 Streptococcus. J Infect Dis. 1973 Dec;128(6):761–768. doi: 10.1093/infdis/128.6.761. [DOI] [PubMed] [Google Scholar]
  6. Overturf G. D., Mortimer E. A., Jr Studies of the relationship between the production of bacteriocines by group A streptococci and acute glomerulonephritis. J Exp Med. 1970 Oct 1;132(4):694–701. doi: 10.1084/jem.132.4.694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Peterson P. K., Schmeling D., Cleary P. P., Wilkinson B. J., Kim Y., Quie P. G. Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis. 1979 May;139(5):575–585. doi: 10.1093/infdis/139.5.575. [DOI] [PubMed] [Google Scholar]
  8. Schofield C. R., Tagg J. R. Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) 1983 Feb;90(1):7–18. doi: 10.1017/s0022172400063774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Simpson W. J., Tagg J. R. M-type 57 group A streptococcus bacteriocin. Can J Microbiol. 1983 Oct;29(10):1445–1451. doi: 10.1139/m83-221. [DOI] [PubMed] [Google Scholar]
  10. Tagg J. R., Bannister L. V. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol. 1979 Nov;12(4):397–411. doi: 10.1099/00222615-12-4-397. [DOI] [PubMed] [Google Scholar]
  11. Tagg J. R., McGiven A. R. Some possible autoimmune mechanisms in rheumatic carditis. Lancet. 1972 Sep 30;2(7779):686–688. doi: 10.1016/s0140-6736(72)92091-0. [DOI] [PubMed] [Google Scholar]
  12. Tagg J. R., Wannamaker L. W. Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother. 1978 Jul;14(1):31–39. doi: 10.1128/aac.14.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tagg J. R., Wong H. K. Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol. 1983 Nov;16(4):409–415. doi: 10.1099/00222615-16-4-409. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES